ask="67.82"
ask_size="100"
average_daily_volume="383200"
bid="66.02"
bid_size="200"
book_value="6.84"
change="-1.75"
change_from_200_day_moving_average="3.42"
change_from_50_day_moving_average="-11.25"
change_from_52_week_high="-22.12"
change_From_52_week_low="33.33"
change_in_percent="-2.57%"
close="66.35"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="1.54"
ebitda="26.14M"
eps_estimate_current_year="4.59"
eps_estimate_next_quarter="1.95"
eps_estimate_next_year="5.58"
ex_dividend_date="N/A"
float_shares="8147000"
high="67.41"
high_52_weeks="88.47"
last_trade_date="1/10/2017"
last_trade_price="66.35"
last_trade_size="19048"
last_trade_time="4:00pm"
low="63.86"
low_52_weeks="33.02"
market_capitalization="1.02B"
moving_average_200_day="62.93"
moving_average_50_day="77.60"
name="Eagle Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="92.75"
open="67.41"
pe_ratio="43.20"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+5.43%"
percent_change_from_50_day_moving_average="-14.50%"
percent_change_from_52_week_high="-25.00%"
percent_change_from_52_week_low="+100.94%"
previous_close="68.10"
price_eps_estimate_current_year="14.46"
price_eps_Estimate_next_year="11.89"
price_per_book="9.96"
price_per_sales="8.31"
revenue="126.52M"
shares_outstanding="15435000"
short_ratio="12.13"
stock_exchange="NGM"
symbol="EGRX"
volume="646407"
weeks_range_52="33.02 - 88.47"
